Zacks Research Lifts Earnings Estimates for ProAssurance

ProAssurance Co. (NYSE:PRA) – Investment analysts at Zacks Research raised their Q3 2025 earnings estimates for ProAssurance in a research note issued on Thursday, March 13th. Zacks Research analyst K. Dey now anticipates that the insurance provider will post earnings of $0.28 per share for the quarter, up from their previous estimate of $0.23. The consensus estimate for ProAssurance’s current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance’s Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.91 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.25 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.30 EPS, FY2026 earnings at $1.06 EPS and FY2027 earnings at $1.17 EPS.

ProAssurance (NYSE:PRA) last announced its earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The business had revenue of $287.52 million during the quarter, compared to analyst estimates of $274.56 million.

Separately, StockNews.com upgraded shares of ProAssurance from a “hold” rating to a “buy” rating in a report on Thursday, March 6th.

ProAssurance Trading Up 0.1 %

Shares of PRA opened at $15.73 on Monday. The firm has a market cap of $804.75 million, a price-to-earnings ratio of 18.95 and a beta of 0.21. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. ProAssurance has a fifty-two week low of $10.76 and a fifty-two week high of $17.79. The firm has a 50 day moving average price of $15.06 and a 200-day moving average price of $15.27.

Hedge Funds Weigh In On ProAssurance

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Mariner LLC lifted its stake in shares of ProAssurance by 4.2% in the 4th quarter. Mariner LLC now owns 17,007 shares of the insurance provider’s stock worth $271,000 after purchasing an additional 688 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of ProAssurance by 4.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,991 shares of the insurance provider’s stock worth $461,000 after purchasing an additional 1,127 shares during the period. Rhumbline Advisers lifted its stake in shares of ProAssurance by 0.8% in the 4th quarter. Rhumbline Advisers now owns 160,707 shares of the insurance provider’s stock worth $2,557,000 after purchasing an additional 1,281 shares during the period. Sterling Capital Management LLC lifted its stake in shares of ProAssurance by 859.4% in the 4th quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider’s stock worth $26,000 after purchasing an additional 1,461 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its holdings in ProAssurance by 0.3% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 587,901 shares of the insurance provider’s stock worth $8,842,000 after acquiring an additional 1,738 shares in the last quarter. Institutional investors own 85.58% of the company’s stock.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.